share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股SEC公告 ·  09/06 09:29

Moomoo AI 已提取核心信息

On September 6, 2024, Safety Shot, Inc., a Delaware-based wellness company, announced the Notice of Allowance for a new U.S. patent for its clinically-backed formula designed to rapidly reduce blood alcohol content (BAC). The patent is a significant addition to the company's portfolio, distinguishing Safety Shot as a leader in a new market category aimed at addressing alcohol-related issues. COO David Sandler and CEO Jarret Boon, co-owners of the patent, emphasized the patent's role in reinforcing the company's competitive edge and its commitment to consumer solutions. Safety Shot's product, which supports alcohol metabolism and reduces toxin buildup, is available online and is expanding into business-to-business sales. The announcement also included forward-looking statements regarding the company's plans and potential risks as disclosed in its SEC filings.
On September 6, 2024, Safety Shot, Inc., a Delaware-based wellness company, announced the Notice of Allowance for a new U.S. patent for its clinically-backed formula designed to rapidly reduce blood alcohol content (BAC). The patent is a significant addition to the company's portfolio, distinguishing Safety Shot as a leader in a new market category aimed at addressing alcohol-related issues. COO David Sandler and CEO Jarret Boon, co-owners of the patent, emphasized the patent's role in reinforcing the company's competitive edge and its commitment to consumer solutions. Safety Shot's product, which supports alcohol metabolism and reduces toxin buildup, is available online and is expanding into business-to-business sales. The announcement also included forward-looking statements regarding the company's plans and potential risks as disclosed in its SEC filings.
2024年9月6日,总部位于特拉华州的健康公司Safety Shot,Inc.宣布其经临床支持的配方获得了新的美国专利的允许通知。该专利是该公司投资组合的重要组成部分,将Safety Shot区分为一个新的市场类别领导者,旨在解决与酒精相关的问题。首席运营官大卫·桑德勒和首席执行官贾瑞特·布恩,作为专利的共有者,强调了该专利在增强公司竞争优势和致力于消费者解决方案方面的作用。Safety Shot的产品支持酒精代谢,并减少毒素积聚,可在线购买,并正在扩展到企业间销售。该公告还包括关于公司计划和潜在风险的前瞻性声明,如其SEC申报文件中所披露的。
2024年9月6日,总部位于特拉华州的健康公司Safety Shot,Inc.宣布其经临床支持的配方获得了新的美国专利的允许通知。该专利是该公司投资组合的重要组成部分,将Safety Shot区分为一个新的市场类别领导者,旨在解决与酒精相关的问题。首席运营官大卫·桑德勒和首席执行官贾瑞特·布恩,作为专利的共有者,强调了该专利在增强公司竞争优势和致力于消费者解决方案方面的作用。Safety Shot的产品支持酒精代谢,并减少毒素积聚,可在线购买,并正在扩展到企业间销售。该公告还包括关于公司计划和潜在风险的前瞻性声明,如其SEC申报文件中所披露的。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息